Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    PR Mobile Headlines    |    Today's News    |    News By Category    |    News By Region    |    News By Date    |    Business Directory    |    Private Branding
All Press Releases for June 06, 2008 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version    Bookmark del.icio.us    Diggs



Trevigen announces the release of Four New Assay Kits for 3-D Cell Proliferation
Trevigen introduces four new 3-D cell proliferation kits, including a core kit and three different kits containing basement membrane extract, laminin I, and collagen I. 
x-small text small text medium text large text


    /24-7PressRelease/ - GAITHERSBURG, MD, June 06, 2008 - Many scientists are converting from growing cells in a traditional 2-D Monolayer on plastic surfaces with tissue culture medium to 3-D Culture. In 3-D Culture, cells are grown in a microenvironment of specialized proteins which mimics in vivo conditions and allows the cells to organize into complex structures rather than uniform monolayers. Various types of cells require different specialized proteins for optimal growth conditions and these extracellular matrices can play an important role in modulating cellular response to pharmacological compounds. For these reasons, conversion to 3-D culture with different matrices is highly desirable, but until now there has not been a practical way to evaluate cell proliferation from 3-D cultures.

Trevigen has an innovative solution with the introduction of four new 3-D cell proliferation kits including a core kit and three different kits containing basement membrane extract, laminin I, and collagen I. These are the first standardized kits engineered for assessing the effects of compounds or genetic alteration on cell proliferation in 3-D culture. The high throughput 96 stripwell formats allow one step quantitative analysis and colorimetric detection. Protocols are provided for tumorgenicity and cytotoxicity.

Trevigen, Inc. is a rapidly growing biotechnology company focused on the development of products and technology for cancer research, emphasizing apoptosis, DNA damage and repair, and cancer cell function and behavior. Trevigen has been a long-standing provider of quality reagents and kits for researchers investigating programmed cell death and DNA damage and repair. A logical extension of the focus on cancer research has been the recent development of assays for cancer cell function and behavior including angiogenesis, cell invasion and tumor formation. Currently, the product portfolio contains over 500 products categorized into four processes " Apoptosis, DNA Damage and Repair, Angiogenesis, and Oxidative Stress. 3-D qualified BME, Laminin I and Collagen I are also available separately from Trevigen. Visit http://www.trevigen.com or contact us at 1800-873-8443 or info@trevigen.com for more information.

# # #


Read more Press Releases from Belinda De Leon:
Other Press Release Headlines:


Press Release Service & Press Release Distribution News Supplied By 24-7PressRelease.com
Press Release Contact Information:
Belinda De Leon
Trevigen, Inc.

Business Development
8405 Helgerman Court
Gaithersburg, MD
USA 20877
Voice: 202-390-2369
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release. We are unable to assist you with any information regarding this release. 24-7 Press Release disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.